Company profile
Xequel Bio
- Industry
- Biotechnology Research
- Employees
- 6
- Headquarters
- Fort Worth, Texas
- LinkedIn followers
- 728
- Office locations
- 2
Xequel Bio company summary
Xequel Bio is a company in the Biotechnology Research industry, headquartered in Fort Worth, Texas. On LinkedIn the company has around 6 employees and 728 followers. The company lists 2 office locations.
What technology does Xequel Bio use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Xequel Bio
Xequel Bio, Inc. is a clinical stage biopharmaceutical company advancing its proprietary aCT1 (alpha-Connexin carboxyl-Terminal 1 peptide) technology platform to develop drugs that will enable physicians to better manage a variety of indications involving inflammation and the body’s response to injury. aCT1 is a patented new chemical entity currently in development for multiple indications. The Company’s lead clinical programs include Granexin® gel in dermatology and iNexinTM ophthalmic solution in ophthalmology. The Company also has ongoing preclinical research in pulmonology.
Where is Xequel Bio located?
Xequel Bio lists 2 office locations.
Compare companies similar to Xequel Bio
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Xequel Bio xequel.com | Biotechnology Research | 6 | - | Fort Worth, Texas |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Xequel Bio
What does Xequel Bio do?
Xequel Bio, Inc. is a clinical stage biopharmaceutical company advancing its proprietary aCT1 (alpha-Connexin carboxyl-Terminal 1 peptide) technology platform to develop drugs that will enable physicians to better manage a variety of indications involving inflammation and the body’s response to injury. aCT1 is a patented new chemical entity currently in development for multiple indications. The Company’s lead clinical programs include Granexin® gel in dermatology and iNexinTM ophthalmic solution in ophthalmology. The Company also has ongoing preclinical research in pulmonology.
How many employees does Xequel Bio have?
Xequel Bio has around 6 employees on LinkedIn.
Where is Xequel Bio headquartered?
Xequel Bio is headquartered in Fort Worth, Texas.
Where does Xequel Bio have offices?
Xequel Bio lists 2 office locations, including Fort Worth, Texas, US; Mount Pleasant, South Carolina, US.
Build a lead list from companies like Xequel Bio
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.